Display Settings:

Format

Send to:

Choose Destination

    Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13403-8. Epub 2008 Aug 29.

    Effects of denaturants and osmolytes on proteins are accurately predicted by the molecular transfer model.

    O'Brien EP, Ziv G, Haran G, Brooks BR, Thirumalai D.

    Biophysics Program, Institute for Physical Science and Technology and Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742, USA.

    Interactions between denaturants and proteins are commonly used to probe the structures of the denatured state ensemble and their stabilities. Osmolytes, a class of small intracellular organic molecules found in all taxa, also profoundly affect the equilibrium properties of proteins. We introduce the molecular transfer model, which combines simulations in the absence of denaturants or osmolytes, and Tanford's transfer model to predict the dependence of equilibrium properties of proteins at finite concentration of osmolytes. The calculated changes in the thermodynamic quantities (probability of being in the native basin of attraction, m values, FRET efficiency, and structures of the denatured state ensemble) with GdmCl concentration [C] for the protein L and cold shock protein CspTm compare well with experiments. The radii of gyration of the subpopulation of unfolded molecules for both proteins decrease (i.e., they undergo a collapse transition) as [C] decreases. Although global folding is cooperative, residual secondary structures persist at high denaturant concentrations. The temperature dependence of the specific heat shows that the folding temperature (T(F)) changes linearly as urea and trimethylamine N-oxide (TMAO) concentrations increase. The increase in T(F) in TMAO can be as large as 20 degrees C, whereas urea decreases T(F) by as much as 35 degrees C. The stabilities of protein L and CspTm also increase linearly with the concentration of osmolytes (proline, sorbitol, sucrose, TMAO, and sarcosine).

    PMID: 18757747 [PubMed - indexed for MEDLINE]

    PMCID: PMC2533202

    Supplemental Content

    Click here to read Click here to read